What is the current valuation of the UK high throughput-screening market?

The market valuation was $872.14 Million in 2024. Read More

What is the projected market valuation for the UK high throughput-screening market by 2035?

The projected valuation for 2035 is $2418.0 Million. Read More

What is the expected CAGR for the UK high throughput-screening market during the forecast period 2025 - 2035?

The expected CAGR is 9.71% during the forecast period. Read More

Which companies are considered key players in the UK high throughput-screening market?

Key players include Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, and others. Read More

What are the main product and service segments in the UK high throughput-screening market?

Main segments include Consumables, Instruments, and Software & Services, with valuations ranging from $200.0 Million to $1100.0 Million. Read More

What technologies are driving the UK high throughput-screening market?

Technologies include Cell-Based Assays, Lab-on-a-Chip (LOC), and Ultra-High-Throughput Screening, with valuations from $100.0 Million to $700.0 Million. Read More

What applications are most prominent in the UK high throughput-screening market?

Prominent applications include Drug Discovery, Biochemical Screening, and Cell & Organ-Based Screening, with valuations from $200.0 Million to $800.0 Million. Read More

Who are the primary end users of high throughput-screening technologies in the UK?

Primary end users include Pharmaceutical and Biotechnology Companies, Research Institutes, and Contract Research Organizations. Read More

What is the valuation range for the Drug Discovery application in the UK high throughput-screening market?

The valuation range for Drug Discovery is from $300.0 Million to $800.0 Million. Read More

How does the UK high throughput-screening market compare to other regions?

While specific regional comparisons are not provided, the UK market is poised for growth, indicated by its projected valuation increase by 2035. Read More

UK High Throughput Screening Market

UK High Throughput Screening Market Research Report: Size, Share, Trend Analysis By Product & Service (Reagents, Assay Kits Instruments, Consumables, Accessories, Software, Services) and By Technology (Cell-Based Assays, 2D Cell Culture, 3D Cell Culture, Scaffold-Based Technologies, Scaffold-free Technologies, Hanging-drop Plates, Ultra-low Binding Plates, Other Scaffold-free Technologies) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

9.71%

2024 Market Size

$ 872.14 Million

2035 Market Size

$ 2,418 Million

Healthcare ● Updated February 2026 Report ID: MRFR/HC/52885-HCR | Pages: 200 | Author: Vikita Thakur, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Product & Services (USD Million)
  1. 4.1.1 Consumables
  2. 4.1.2 Instruments
  3. 4.1.3 Software & Services
2. 4.2 Healthcare, BY Technology (USD Million)
  1. 4.2.1 Cell-Based Assays
  2. 4.2.2 Lab-on-a-Chip (LOC)
  3. 4.2.3 Ultra-High-Throughput Screening
  4. 4.2.4 Label-Free Technology
  5. 4.2.5 Others
3. 4.3 Healthcare, BY Application (USD Million)
  1. 4.3.1 Drug Discovery
  2. 4.3.2 Biochemical Screening
  3. 4.3.3 Cell & Organ-Based Screening
  4. 4.3.4 Others
4. 4.4 Healthcare, BY End User (USD Million)
  1. 4.4.1 Pharmaceutical and Biotechnology Companies
  2. 4.4.2 Research Institutes and Organizations
  3. 4.4.3 Contract Research Organizations
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Agilent Technologies (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 PerkinElmer (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Becton Dickinson (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Merck KGaA (DE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Tecan Group (CH)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Sartorius AG (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Corning Incorporated (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Bio-Rad Laboratories (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY PRODUCT & SERVICES
3. 6.3 UK MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 UK MARKET ANALYSIS BY APPLICATION
5. 6.5 UK MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY PRODUCT & SERVICES, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY PRODUCT & SERVICES, 2024 TO 2035 (USD Million)
14. 6.14 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
16. 6.16 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
18. 6.18 HEALTHCARE, BY END USER, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT & SERVICES, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK High Throughput Screening Market Segmentation

UK High Throughput Screening Market By Product & Services (USD Million, 2025-2035)

Consumables
Instruments
Software & Services

UK High Throughput Screening Market By Technology (USD Million, 2025-2035)

Cell-Based Assays
Lab-on-a-Chip (LOC)
Ultra-High-Throughput Screening
Label-Free Technology
Others

UK High Throughput Screening Market By Application (USD Million, 2025-2035)

Drug Discovery
Biochemical Screening
Cell & Organ-Based Screening
Others

UK High Throughput Screening Market By End User (USD Million, 2025-2035)

UK High Throughput Screening Market and Biotechnology Companies
Research Institutes and Organizations
Contract Research Organizations

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”